Furthermore, causal estimates derived from MR do not necessarily mirror the effects seen in clinical practice, as demonstrated by the hitherto lack of effect of PCSK9 inhibition on increasing the risk of type 2 diabetes in RCTs.76–79. This evidence concerns the gene PCSK9 and type 2 diabetes mellitus.